Mohs micrographic surgery for the treatment of melanoma.

Dermatologic clinics (2012-07-18)
Andrea M Hui, Michael Jacobson, Orit Markowitz, Norman A Brooks, Daniel M Siegel
ABSTRACT

For melanoma treatment, the primary goal is complete removal with histologically negative margins. Mohs micrographic surgery (MMS) has been extensively used and studied for the treatment of nonmelanoma skin cancer, particularly at sites where tissue conservation is vital. The use of MMS for melanoma treatment has yet to become widely accepted owing to difficulties in histologic interpretation, among other factors. MMS may offer lower recurrence rates and improved survival when compared with historical controls for standard excision. Continued advances in MMS technique and immunohistochemical staining have allowed the technique to gain further support.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Zinc chloride, reagent grade, ≥98%
Sigma-Aldrich
Zinc chloride, 99.999% trace metals basis
Sigma-Aldrich
Zinc chloride, anhydrous, powder, ≥99.995% trace metals basis
Sigma-Aldrich
Zinc chloride, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Zinc chloride 0.1 M solution
Sigma-Aldrich
Zinc chloride solution, 1.9 M in 2-methyltetrahydrofuran
Sigma-Aldrich
Zinc chloride solution, 0.5 M in THF
Sigma-Aldrich
Zinc chloride solution, 1.0 M in diethyl ether
Sigma-Aldrich
Zinc chloride, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥98%
Sigma-Aldrich
Zinc chloride, ACS reagent, ≥97%
Sigma-Aldrich
Zinc chloride, puriss., meets analytical specification of Ph. Eur., BP, USP, 98-100.5%
Sigma-Aldrich
Zinc chloride, AnhydroBeads, amorphous, −10 mesh, 99.99% trace metals basis
Sigma-Aldrich
Zinc chloride, AnhydroBeads, amorphous, −10 mesh, 99.999% trace metals basis

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.